Some scholars found that the abnormal expression of C-MYC in ovarian cancer cells could lead to significant changes in the expression level of NCOA4, as well as the content of ferritin and Fe2+ [30,31,32,33,34]. The gene discussed is NCOA4; the disease is ovarian carcinoma.